These findings suggest a novel form of PTM for p53 that is critical in maintaining the activation of the p53 pathway, which is a part of an epigenetic regulatory loop between ZDHHC1 and p53, thus shedding light on the regulation of p53 pathway without the occurrence of genetic mutations and providing potential therapeutic targets for the battle against cancer. This evidence concerns the gene ZDHHC1 and cancer.